skip to content
 

List of Deliverables in Chronological Order

 

No.

Deliverable Name

Lead

Type

Level

Month

2.0

Preparation for Import of materials to Ghana. Submission to FDA (and export from EU)

KCCR

Other

CO

0

2.1

Define end-user needs including the number of NAT systems and chips require for clinical testing

KCCR

R

CO

1

4.1

Description of model for pooled samples at low, medium and high prevalences of COVID-19

DTU

R

PU

1

1.1

Project handbook and communications/documentation tools for file sharing and discussion

UCAM

R

CO

2

6.1

Study protocol and supporting documents completed

KNUST

R

PU

2

6.2

Confirmation of study set up, recruitment and training of staff

KNUST

R

PU

3

6.3

Institutional and regulatory approvals obtained (KNUST, UCAM)

KNUST

R

PU

3

2.2

PATHPOD systems and chips delivered for clinical testing in Ghana

DTU

DEM

CO

3

9.1

Visual identity pack and website

UCAM

DEC

PU

3

3.1

Engineered Boon2-BST and accompanying expression and purification SOP

UCAM

DEM

PU

4

9.2

Publication of Plan for Exploitation and Dissemination of Results

UCAM

R

PU

4

9.3

AfriDx Fact or Myth? Posts and explanatory short articles

DTU

DEC

PU

4

2.3

Remote training course for use of PATHPOD system and chips

DTU

R

CO

5

2.4

Workflow for PATHPOD use in Ghana to detect COVID-19

DTU

DEM

CO

5

5.1

Modified and characterised high-affinity scFv

UCAM

DEM

PU

5

4.2

Dataset for limit of detection and report on recommendations for clinical study design

KNUST

R

CO

6

5.2

Purified covid coat protein fragments

UCAM

DEM

PU

6

8.1

AfriDx Manufacturing course handbook and SOPs

UCAM

R

PU

6

7.1

Report and dataset on legal and regulatory landscape for PATHPOD and similar IVDs in Ghana

TATAA

R

PU

6

3.2

Engineered Boon2-RT and accompanying expression and purification SOP

UCAM

DEM

PU

7

1.2

List of initial Advisory Board members on website

UCAM

R

PU

7

1.3

Midterm Report

UCAM

R

PU

8

6.4

Provide data for midterm report

KNUST

R

CO

8

3.3

Application of Boon-enzymes in RT-LAMP protocol to detect SARS-Cov-2

KNUST

DEM

PU

9

6.5

Comparative sample testing completed

KNUST

R

CO

10

9.4

Video interviews with partners and stakeholders

UCAM

DEC

PU

10

1.4

Inaugural Advisory Board meeting

UCAM

Other

PU

11

3.4

Demonstrate the Boon-RT and BST production at 1-2 L

UCAM

DEM

CO

11

6.6

Record of data collection and analysis

KNUST

R

CO

12

7.2

Commercialization plan for the Ghanaian

TATAA

R

CO

12

8.2

AfriDx and AfriMx user course handbook and SOPs

NMIMR

R

PU

12

3.5

Engineered Boon2-scFV and accompanying expression and purification SOP

UCAM

DEM

PU

14

1.5

EDCTP progress reports and financial reports

UCAM

R

CO

15

5.3

AfriMx protocol and SOP

UCAM

R

PU

15

5.4

Testing pre-screened clinical serum samples with AfriMx

KNUST

DEM

PU

15

6.7

Publication of study report

KNUST

R

PU

15

7.3

Regulatory information compiled for IVD use in Ghana, in anticipation of future filing

TATAA

R

CO

15

8.3

AfriDx-KIT DNA collection, user course handbook and SOPs

UCAM

R

PU

15

9.5

AfriDx policy briefs in electronic and printable format

UCAM

DEC

PU

15